Many patients with Crohn's disease carry mutations in NOD2, a molecule that can both activate and attenuate the pro-inflammatory effects of NF-κ κB. Recent studies implicate NOD2-induced ubiquitination of the NF-κ κB regulator NEMO as a potential means of manipulating the NF-κ κB signal. In order to try to understand more about this complexity, we need to examine the activation of NF-κ κB, which requires the Iκ κB kinase (IKK) signalosome, a protein complex composed of two kinase subunits (IKK-α α and IKK-β β) and an essential non-catalytic subunit, NEMO. As its name implies, the IKK signalosome is responsible for the phosphorylation of Iκ κB 
proteins, which normally sequester NF-κ κB in the cytoplasm. Iκ κB phosphorylation triggers its ubiquitination and ultimately its proteolytic degradation by the 26S proteasome, freeing NF-κ κB to enter the nucleus and activate transcription [6] . Despite the diversity of signals and signaling cascades activating NF-κ κB, all classical pathways induce the assembly and activation of the IKK signalosome. This pivotal position demands that the IKK signalosome recognize and presumably integrate distinct signaling cascades. NEMO, in particular its carboxyl terminus, is considered the logical integrator/regulatory unit ( Figure 2 ). While NEMO is reported to bind to some signaling proteins, the convergence of different signals at the IKK signalosome is, for the most part, unexplained [7] . The formation of such a network could provide a simple mechanism by which ubiquitinated NEMO could be incorporated into diverse signaling complexes and establish a means of activating the IKK signalosome by recruiting its regulators or inducing a conformational change leading to activation of IKK-β β by transphosphorylation. Conversely, destruction of ubiquitin-dependent interactions could provide a straightforward means of limiting the intensity and/or inhibiting a given signaling cascade. In support of this idea, two potent negative regulators of NF-κ κB, the tumor suppressor gene product CYLD and A20, turn out to be deubiquitinating enzymes that specifically remove K63-linked polyubiquitin chains [13, 14] .
Several other stimuli are now also known to induce NEMO ubiquitination, including TNFα α, T-cell receptor (TCR) signaling, and genotoxic stress. Consistent with a fundamental role in IKK signalosome activation via these stimuli, NEMO ubiquitination is necessary for full NF-κ κB activity. In the case of TCR-induced ubiquitination, which was also demonstrated to trigger K63-linked chains on NEMO, oligomerization of key signaling proteins (Bcl10-paracaspase/MALT1-TRAF6) leads to the assembly of a ubiquitin ligase complex that specifically targets K399 of NEMO [8, 15] . Interestingly, although NOD2-RIP2-triggered ubiquitination of NEMO may also occur at this site, NOD-RIP2 triggers K63-linked ubiquitination at K285 of NEMO (Figure 2) . A precedent for diversity within the ubiquitination profile of NEMO already exists, given that TNFα α triggers K6-linked (not K63-linked) ubiquitin on NEMO [9] , and DNA-damage-induced ubiquitination of NEMO requires that the selected lysines, in this case 277 and 309, are first conjugated by the small ubiquitin-like modifier SUMO prior to ubiquitination [10] . These findings point to the intriguing possibility that specific ubiquitin profiles on NEMO may integrate various responses, orchestrating a specific repertoire of gene activation. Given the recent finding that NOD2 negatively regulates the inflammatory responses of the Tolllike receptor 2 pathway, it will be interesting to test the role of NEMO ubiquitination at K285 in this context [5] .
From the recent work of Cantley and colleagues [2] and other groups, several generalizations can be drawn. Firstly, the use of networks of ubiquitin-binding and ubiquitinated proteins culminating at ubiquitinated NEMO may be a common mechanism in diverse signaling cascades for activation of the IKK signalosome. It seems likely that other NF-κ κB signaling proteins and other ubiquitin-binding proteins will be uncovered. Secondly, localized regions of these ubiquitin networks will inevitably be destroyed, at least during normal transient responses to a stimulus, through the action of deubiquitinating enzymes like A20 and CYLD. Interestingly, some pathogenic bacteria contain proteases that may be involved in the removal of ubiquitin or ubiquitin-like molecules [16] , raising the question of whether bacteria, which are known to contribute to the development of Crohn's disease, do so by exploiting ubiquitin networks. Further work delineating the mechanism and specific function of NOD2-RIP2-induced ubiquitination of NEMO at K285 is likely to increase our understanding of the role of NEMO in the NF-κ κB response and possibly point to how deregulation of this particular pathway may be involved in Crohn's disease and other autoinflammatory disorders. Current Biology
